Full Text
EE425 Cost-Effectiveness Analysis of Rivaroxaban Vs Other Anticoagulants

Abstract

Authors

M Figallo S Manrique N Colunge D Castañeda Aliaga M Chavez R Marrugo C Lopez

Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×